Meditoxin recorded a market capitalization of 1 trillion won briefly after entering the Indonesian market with hyaluronic acid fillers.
Kim Jisun
stockmk2020@alphabiz.co.kr | 2024-06-24 06:39:28
Medytox.(photo=medytox)
[Alpha Biz= Reporter Kim Jisun] Medytox saw a strong surge in its stock price as it opened up a new avenue for selling its new hyaluronic acid filler products in Indonesia.
According to the Korea Exchange on the 23rd, Medytox closed at 136,900 won, up 6.37% (8,200 won) from the previous day. At one point, it traded as high as 141,100 won on the KOSDAQ market, briefly reaching a market capitalization of around 1 trillion won.
Earlier, on the 20th, Medytox announced it had obtained regulatory approval in Indonesia for three types of hyaluronic acid (HA) fillers. These fillers inject hyaluronic acid, a biocompatible substance that softens joints or skin, under the skin to improve wrinkles.
[ⓒ AlphaBIZ. 무단전재-재배포 금지]
많이 본 기사
- 1Korean Low-Cost Carriers Cut Routes as Oil Prices and Currency Surge Amid Middle East Tensions
- 2KakaoBank App Outage Occurred Twice Due to Misdiagnosed Cause, Lawmaker Raises Concerns
- 3Aekyung Chemical to Sell China Subsidiary After Halting Operations
- 4DB HiTek Minority Shareholders Urge Forced Disposal of Alleged Hidden Stake by Founder
- 5Samsung Electronics GOS Lawsuit Over Galaxy S22 Ends After Four Years with Court-Mediated Settlement
- 6Toss Removes “Han River Temperature” Feature After Backlash Over Insensitive Messaging